Methicillin-resistant Staphylococcus aureus screening as a patient safety initiative: using patients’ experiences to improve the quality of screening practices
Article first published online: 21 SEP 2013
© 2013 John Wiley & Sons Ltd
Journal of Clinical Nursing
Volume 23, Issue 1-2, pages 221–231, January 2014
How to Cite
Currie, K., Knussen, C., Price, L. and Reilly, J. (2014), Methicillin-resistant Staphylococcus aureus screening as a patient safety initiative: using patients’ experiences to improve the quality of screening practices. Journal of Clinical Nursing, 23: 221–231. doi: 10.1111/jocn.12366
- Issue published online: 9 DEC 2013
- Article first published online: 21 SEP 2013
- Manuscript Accepted: 25 MAR 2013
- Scottish Government Health Department
- health screening;
- infection control;
- information needs;
- patient experience;
Aims and objectives
To explore the patient experience and acceptability of methicillin-resistant Staphylococcus aureus screening of inpatient admissions to acute hospital settings.
Prevention of healthcare-associated infections such as methicillin-resistant Staphylococcus aureus is a major patient safety concern internationally. Screening of patients for methicillin-resistant Staphylococcus aureus colonisation is becoming a routine aspect of hospital admission; however, evidence of the patient experience and acceptability of methicillin-resistant Staphylococcus aureus screening is limited.
A mixed-methods study set in six acute care hospitals in three Scottish regions.
Data collection involved postdischarge self-report survey of patients who had been screened (n = 54) and qualitative patient interviews (n = 10). Theoretical constructs derived from the Health Belief Model and Theory of Planned Behaviour used in analysis.
Findings indicated that methicillin-resistant Staphylococcus aureus screening was broadly acceptable to patients. The experience of screening did not appear to be problematic; responses demonstrate that screening provided reassurance and generated confidence that health organisations were tackling healthcare-associated infections. Patients were less positive regarding the provision of information, the possibility of refusing a screen and the consequences of a positive test result. Furthermore, there were indications that patients wanted to be told the results of the screen and strong support for screening of hospital staff.
Analysis of constructs from our theoretical frameworks provides evidence that attitudes were largely positive; responses indicate a belief in the beneficial impact of methicillin-resistant Staphylococcus aureus screening for patients and the wider community. However, it is important that health professionals continually assess the patient experience of ‘routine’ aspects of health care such as MRSA screening.
Relevance to clinical practice
The findings from this study suggest that while methicillin-resistant Staphylococcus aureus screening is generally acceptable to patients as a regular patient safety initiative, to enhance the quality of the patient experience, clinicians should consider the timing, content and effectiveness of information provision.